FDA Drug Recalls

Recalls / Class II

Class IID-1650-2015

Product

Testosterone USP (10 AQUEOUS) 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN

Affected lot / code info
All lots distributed between November 2014 and May 2015; 01122015@25, 7/11/2015; 02232015@48, 8/22/2015; 03242015, 9/20/2015

Why it was recalled

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Recalling firm

Firm
The Compounding Pharmacy of America
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
6216 Highland Place Way Ste 101-A, Knoxville, Tennessee 37919-4068

Distribution

Quantity
49 ml
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-06-02
FDA classified
2015-09-15
Posted by FDA
2015-09-23
Terminated
2016-02-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1650-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls